UQDI Seminar Series guest speaker Professor Richard Lock PRESENTS: 'Preclinical models for personalised approaches in the treatment of childhood leukaemia'
September is Childhood Cancer Awareness Month so the University of Queensland's Diamantina Institute have organised a special speaker to share their research in the area of children's Leukaemia.
Professor Richard Lock was recruited as Head of Children’s Cancer Institute’s Leukaemia Biology Program in 1998 from the position of Associate Professor, Department of Medicine and Department of Biochemistry and Molecular Biology, University of Louisville, Kentucky, USA. Prior to his move, he had attained an international reputation in the cancer-related fields of cell cycle control, drug resistance and mechanisms of programmed cell death (apoptosis).
Since arriving at Children’s Cancer Institute, Richard has successfully developed a clinically relevant laboratory model for the in vivo growth of human acute lymphoblastic leukaemia cells – the first such model in Australia. The model now plays a central role in the preclinical evaluation of anticancer agents and the identification of new targets for targeted therapies.
Richard’s contribution to cancer research has been reflected in his authorship of 159 peer-reviewed papers, including several in prestigious journals such as Blood, Cancer Research, Cell Stem Cell, Clinical Cancer Research, The Journal of Biological Chemistry, Molecular and Cellular Biology, and Oncogene. He is currently a National Health and Medical Research Council Senior Research Fellow, and has been awarded research grants by the National Cancer Institute (USA), The Cancer Council NSW (Australia), and the National Health and Medical Research Council (Australia).
